Institutional Ownership
Ars Pharmaceuticals Inc
CUSIP 82835W108COMSPRYQ1 2026
13D / 13G Filings
39
Schedule 13D/13G on record
Beneficial Filers
18
Distinct reporting persons
Largest Stake
22.4%
Max % of class reported
Institutional Holders
194
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
39 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Rubric Capital Management LP | 13G | 6.3% | 6.20M | SEC |
| 2 | Jan 21, 2026 | Blackrock, Inc. | 13G | 5.1% | 5.01M | SEC |
| 3 | Oct 1, 2025 | Ra Capital Management, L.P. | 13D/A | 11.1% | — | SEC |
| 4 | Aug 1, 2025 | Deerfield Mgmt III, L.P. | 13D/A | 7.8% | — | SEC |
| 5 | Jul 22, 2025 | Deerfield Mgmt III, L.P. | 13D/A | 8.8% | — | SEC |
| 6 | Jul 2, 2025 | Deerfield Mgmt III, L.P. | 13D/A | 9.9% | — | SEC |
| 7 | Mar 24, 2025 | Deerfield Mgmt III, L.P. | 13D/A | 10.7% | — | SEC |
| 8 | Jun 17, 2024 | Pratik Shah Living Trust Dated June 15, 2011 | 13D/A | 5.4% | 5.22M | SEC |
| 9 | Jun 11, 2024 | Pratik Shah Living Trust Dated June 15, 2011 | 13D/A | 6.8% | 6.55M | SEC |
| 10 | Mar 29, 2024 | Ra Capital Management, L.P. | 13D/A | 11.3% | 10.86M | SEC |
29 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Ars Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 10.86M | $87.21M |
| 2 | Orbimed Advisors LLC | 8.29M | $66.56M |
| 3 | Rubric Capital Management LP | 8.00M | $64.24M |
| 4 | Deerfield Management Company, L.P. | 7.50M | $60.26M |
| 5 | Millennium Management LLC | 5.98M | $48.04M |
| 6 | Blackrock, Inc. | 5.01M | $40.25M |
| 7 | Aberdeen Group PLC | 4.11M | $33.03M |
| 8 | Sr One Capital Management, LP | 4.01M | $32.22M |
| 9 | State Street Corp | 3.64M | $29.27M |
| 10 | Franklin Resources Inc | 3.28M | $26.33M |